Skip to content
akaturk Academic measurement

Article detail · 2022

Can the Antivirals Remdesivir and Favipiravir Work Better Jointly? In Silico Insights

Drug Research

YÖKSİS OpenAlex ISSN 2194-9379 DOI 10.1055/a-1585-1323 Citations 10 SJR Q3

10.1055/a-1585-1323

YÖKSİS YÖKSİS article record

OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex record

English (OpenAlex)

The proverb "Old is gold" is applicable in drug discovery and the proverb "All that Glitters is not Gold" is also appropriate. In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus but none have been conclusive so far. In the attempts for innovations, the combination of drugs is also under trials. Therefore, we used the density functional theory method and quantum theory of atoms in molecules to investigate drug-drug interactions involving Remdesivir and Favipiravir. The computed parameters were related to the antiviral actions of both drugs together. The results indicate enhanced antiviral activity and it will be worthy to consider additional investigations with the combination of these two drugs.

OpenAlex enrichment

Topics

  • Synthesis and biological activity
  • Nonlinear Optical Materials Research
  • Structural and Chemical Analysis of Organic and Inorganic Compounds

Type: article Synthesis and biological activity

Index information

WoS (JCR) and Scopus (SJR) quartiles by ISSN and publication year. · 2022

Scopus (SJR) / WoS (JCR)

Drug Research

Scopus (SJR) Q3 0,363 Year 2022
WoS (JCR) JIF 2,2 Year 2022

Universities

  • ESKİŞEHİR TEKNİK ÜNİVERSİTESİ

Authors

  1. CEMAL PARLAK
  2. ÖZGÜR ALVER ESKİŞEHİR TEKNİK ÜNİVERSİTESİ
  3. CECIL N.M. OUMA
  4. LYDIA RHYMAN
  5. PONNADURAI RAMASAMI